Previously, using an in vitro model of cisplatin-resistant NSCLC, we identified and characterised an ALDH1+ve CSC subset that is present across each NSCLC histological subtype [27]. This evidence concerns the gene ALDH1A1 and non-small cell lung carcinoma.